This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes
Gut Pathogens Open Access 30 November 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Putney, S.D. et al. 1983. Nature 302: 718–721.
Cooper, T.A. et al. 1984. Science 226: 979–982.
Zipkin, I. et al. October 20, 1997. BioCentury: The Bernstein Report on BioBusiness. p. A5.
Reddy D.S. et al. 1996. Methods Find. Exp. Clin. Pharmacol. 18: 261–271.
Jerkovic, R. et al. 1997. Cell Struct. Funct. 22: 147–153.
Olschwang, S. et al. 1997. Proc. Natl. Acad. Sci. USA 94: 12122–12127.
Persidis, A. 1997. Nature Biotechnol. 15: 1409–1411.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Persidis, A. The business of pharmacogenomics. Nat Biotechnol 16, 209–210 (1998). https://doi.org/10.1038/nbt0298-209
Issue Date:
DOI: https://doi.org/10.1038/nbt0298-209
This article is cited by
-
Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes
Gut Pathogens (2012)
-
Revisión de análisis económicos sobre tecnologías emergentes en oncología
PharmacoEconomics Spanish Research Articles (2009)
-
Ethical problems in pharmacogenetic studies of psychiatric disorders
The Pharmacogenomics Journal (2006)
-
An empirical survey on biobanking of human genetic material and data in six EU countries
European Journal of Human Genetics (2003)
-
Ethical perspectives on pharmacogenomic profiling in the drug development process
Nature Reviews Drug Discovery (2002)